HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Coty enters Chinese market

This article was originally published in The Rose Sheet

Executive Summary

Coty enters Chinese market: Cosmetics and fragrance manufacturer's joint venture with Yue-Sai Kan Cosmetics in the People's Republic of China will serve as an entry into the "emerging" Asian market, Coty announced June 3. Terms of the deal were not disclosed. "The leading prestige cosmetics company" in China, according to the Benckiser division, Yue-Sai Kan distributes its products in 450 stores. Coty's initial plans under the deal will focus on growing Yue-Sai Kan's presence in China, with the goal of tripling sales in the next five years, the company said. Although plans to introduce Yue-Sai Kan products into the U.S. are not imminent, Coty noted that it is considering expanding the Chinese cosmetics company's products beyond China, possibly including the U.S. The firm also said the deal serves as a potential platform for distribution of Coty's products in China...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel